Lakshmi B. Potluri

Internal Medicine

6071 W Outer Dr
Detroit, MI 48235

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 7 publications

Pomalidomide improved immune profiles in myeloma.

Pomalidomide improved immune profiles in myeloma.

Journal: Oncoscience

Published: December 17, 2024

Immunomodulation of NK, NKT and B/T cell subtypes in relapsed/refractory multiple myeloma patients treated with pomalidomide along with velcade and dexamethasone and its association with improved progression-free survival.

Immunomodulation of NK, NKT and B/T cell subtypes in relapsed/refractory multiple myeloma patients treated with pomalidomide along with velcade and dexamethasone and its association with improved progression-free survival.

Journal: Frontiers in oncology

Published: August 02, 2023

ABL1 kinase plays an important role in spontaneous and chemotherapy-induced genomic instability in multiple myeloma.

ABL1 kinase plays an important role in spontaneous and chemotherapy-induced genomic instability in multiple myeloma.

Journal: Blood

Published: June 05, 2023

Development and validation of a deep transfer learning-based multivariable survival model to predict overall survival in lung cancer.

Development and validation of a deep transfer learning-based multivariable survival model to predict overall survival in lung cancer.

Journal: Translational lung cancer research

Published: December 05, 2022

Two primary cancers appeared after discontinuation of nivolumab in the course of treating Hodgkin lymphoma: a case report.

Two primary cancers appeared after discontinuation of nivolumab in the course of treating Hodgkin lymphoma: a case report.

Journal: AME case reports

Published: November 04, 2022

Elevated APE1 Dysregulates Homologous Recombination and Cell Cycle Driving Genomic Evolution, Tumorigenesis, and Chemoresistance in Esophageal Adenocarcinoma.

Elevated APE1 Dysregulates Homologous Recombination and Cell Cycle Driving Genomic Evolution, Tumorigenesis, and Chemoresistance in Esophageal Adenocarcinoma.

Journal: Gastroenterology

Published: October 31, 2022

Dysregulated APOBEC3G causes DNA damage and promotes genomic instability in multiple myeloma.

Dysregulated APOBEC3G causes DNA damage and promotes genomic instability in multiple myeloma.

Journal: Blood cancer journal

Published: March 13, 2021

Showing 1-7 of 7

Last Updated: 09/26/2026